Clinical Trial Update: Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating S-1, S-1 with cisplatin, and 5-FU with cisplatin for advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-FU/CDDP (5-fluorouracil with cisplatin)
• S-1 (tegafur/gimeracil/oteracil)
• S-1/CDDP (S-1 with cisplatin (tegafur/gimeracil/oteracil with cisplatin))

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED